haloperidol drug
Evidence from:
primary |
all sources
Related entities (6)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| haloperidol | risk_factor_for | cognition | — | 1 |
| haloperidol | regulates | ERN | — | 1 |
| haloperidol | targets | MCHR1 | — | 1 |
| haloperidol | interacts_with | monkeys | — | 1 |
| haloperidol | protective_against | psychosis | — | 1 |
| haloperidol | interacts_with | Δ9-THC | — | 1 |
Mentioned in (11)
Papers in which this entity is mentioned.
- Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology. (2021)
- CommonMind Consortium provides transcriptomic and epigenomic data for Schizophrenia and Bipolar Disorder. (2019)
- A review of the nonpressor and nonantidiuretic actions of the hormone vasopressin. (2015)
- Baths salts, spice, and related designer drugs: the science behind the headlines. (2014)
- Glutamatergic transmission in schizophrenia: from basic research to clinical practice. (2012)
- The contributions of disease and genetic factors towards regional cortical thinning in schizophrenia: the UCLA family study. (2010)
- Cannabis and psychosis/schizophrenia: human studies. (2009)
- The error-related negativity (ERN) and psychopathology: toward an endophenotype. (2008)
- Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. (2008)
- Association study of Wnt signaling pathway genes in bipolar disorder. (2008)
- Causes and consequences of methamphetamine and MDMA toxicity. (2006)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| haloperidol | drug | 11 | 15 |